Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Murali Gopalakrishnan

Showing results (41-50 of 83) with videos related to

Pageof 9
Sort By:
The Journal of Biological Chemistry|June 3, 2006
Association of Catsper1 or -2 with Ca(v)3.3 leads to suppression of T-type calcium channel activityDi Zhang, Jun Chen, Anita Saraf, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 18, 2002
(-)-(9S)-9-(3-Bromo-4-fluorophenyl)-2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637): a novel ATP-sensitive potassium channel opener efficacious in suppressing urinary bladder contractions. II. in vivo characterizationMichael E Brune, Thomas A Fey, Jorge D Brioni, et al.
Neurourology and Urodynamics|February 13, 2003
Effects of ATP-sensitive K+ channel openers and tolterodine on involuntary bladder contractions in a pig model of partial bladder outlet obstructionThomas A Fey, Murali Gopalakrishnan, James G Strake, et al.
Assay and Drug Development Technologies|April 20, 2004
Automated Parallel Oocyte Electrophysiology Test station (POETs): a screening platform for identification of ligand-gated ion channel modulatorsChar-Chang Shieh, Jonathan D Trumbull, Jay F Sarthy, et al.
IS&T International Symposium on Electronic Imaging|December 1, 2025
Scale-up Unlearnable Examples Learning with High-Performance ComputingYanfan Zhu, Issac Lyngaas, Murali Gopalakrishnan Meena, et al.
Bioorganic & Medicinal Chemistry Letters|May 29, 2002
Structure-Activity studies for a novel series of tricyclic dihydropyrimidines as K(ATP) channel openers (KCOs)Irene Drizin, Mark W Holladay, Lin Yi, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 25, 2009
In vitro pharmacological characterization of a novel allosteric modulator of alpha 7 neuronal acetylcholine receptor, 4-(5-(4-chlorophenyl)-2-methyl-3-propionyl-1H-pyrrol-1-yl)benzenesulfonamide (A-867744), exhibiting unique pharmacological profileJohn Malysz, Jens Halvard Grønlien, David J Anderson, et al.
Journal of Cardiovascular Pharmacology|July 10, 2004
(-)-(9S)-9-(3-Bromo-4-fluorophenyl)-2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637), a novel ATP-sensitive potassium channel opener: hemodynamic comparison to ZD-6169, WAY-133537, and nifedipine in the anesthetized canineRyan M Fryer, Lee C Preusser, Samuel V Calzadilla, et al.
Bioorganic & Medicinal Chemistry Letters|May 18, 2010
Syntheses and structure-activity relationship (SAR) studies of 2,5-diazabicyclo[2.2.1]heptanes as novel alpha7 neuronal nicotinic receptor (NNR) ligandsTao Li, William H Bunnelle, Keith B Ryther, et al.
British Journal of Pharmacology|January 24, 2003
Pharmacological characterization of a 1,4-dihydropyridine analogue, 9-(3,4-dichlorophenyl)-3,3,6,6-tetramethyl-3,4,6,7,9,10-hexahydro-1,8(2H,5H)-acridinedione (A-184209) as a novelK(ATP) channel inhibitorMurali Gopalakrishnan, Thomas R Miller, Steven A Buckner, et al.
Pageof 9

Showing results (41-50 of 83) with videos related to

Sort By:
Pageof 9
The Journal of Biological Chemistry|June 3, 2006
Association of Catsper1 or -2 with Ca(v)3.3 leads to suppression of T-type calcium channel activityDi Zhang, Jun Chen, Anita Saraf, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 18, 2002
(-)-(9S)-9-(3-Bromo-4-fluorophenyl)-2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637): a novel ATP-sensitive potassium channel opener efficacious in suppressing urinary bladder contractions. II. in vivo characterizationMichael E Brune, Thomas A Fey, Jorge D Brioni, et al.
Neurourology and Urodynamics|February 13, 2003
Effects of ATP-sensitive K+ channel openers and tolterodine on involuntary bladder contractions in a pig model of partial bladder outlet obstructionThomas A Fey, Murali Gopalakrishnan, James G Strake, et al.
Assay and Drug Development Technologies|April 20, 2004
Automated Parallel Oocyte Electrophysiology Test station (POETs): a screening platform for identification of ligand-gated ion channel modulatorsChar-Chang Shieh, Jonathan D Trumbull, Jay F Sarthy, et al.
IS&T International Symposium on Electronic Imaging|December 1, 2025
Scale-up Unlearnable Examples Learning with High-Performance ComputingYanfan Zhu, Issac Lyngaas, Murali Gopalakrishnan Meena, et al.
Bioorganic & Medicinal Chemistry Letters|May 29, 2002
Structure-Activity studies for a novel series of tricyclic dihydropyrimidines as K(ATP) channel openers (KCOs)Irene Drizin, Mark W Holladay, Lin Yi, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 25, 2009
In vitro pharmacological characterization of a novel allosteric modulator of alpha 7 neuronal acetylcholine receptor, 4-(5-(4-chlorophenyl)-2-methyl-3-propionyl-1H-pyrrol-1-yl)benzenesulfonamide (A-867744), exhibiting unique pharmacological profileJohn Malysz, Jens Halvard Grønlien, David J Anderson, et al.
Journal of Cardiovascular Pharmacology|July 10, 2004
(-)-(9S)-9-(3-Bromo-4-fluorophenyl)-2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637), a novel ATP-sensitive potassium channel opener: hemodynamic comparison to ZD-6169, WAY-133537, and nifedipine in the anesthetized canineRyan M Fryer, Lee C Preusser, Samuel V Calzadilla, et al.
Bioorganic & Medicinal Chemistry Letters|May 18, 2010
Syntheses and structure-activity relationship (SAR) studies of 2,5-diazabicyclo[2.2.1]heptanes as novel alpha7 neuronal nicotinic receptor (NNR) ligandsTao Li, William H Bunnelle, Keith B Ryther, et al.
British Journal of Pharmacology|January 24, 2003
Pharmacological characterization of a 1,4-dihydropyridine analogue, 9-(3,4-dichlorophenyl)-3,3,6,6-tetramethyl-3,4,6,7,9,10-hexahydro-1,8(2H,5H)-acridinedione (A-184209) as a novelK(ATP) channel inhibitorMurali Gopalakrishnan, Thomas R Miller, Steven A Buckner, et al.
Pageof 9